ArticleScientific reports2025

Anti-tumor efficacy and Vδ2 T-cell activation via EGFR antibody-drug conjugates featuring novel aminobisphosphonates.

Doretta Cuffaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.